2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors

[1]  Zhemin Shen,et al.  A Quantitative-Structure-Activity-Relationship (QSAR) model for the reaction rate constants of organic compounds during the ozonation process at different temperatures , 2018, Chemical Engineering Journal.

[2]  M. Çulha,et al.  Quantitative structure-activity relationship between antioxidant capacity of phenolic compounds and the plasmonic properties of silver nanoparticles. , 2018, Talanta.

[3]  P. Mehrbod,et al.  Immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus , 2018, BMC Complementary and Alternative Medicine.

[4]  Inês P. D. Costa,et al.  Studies on neuraminidase inhibition , 2018 .

[5]  A. Chowdhary,et al.  Design, synthesis and evaluation of chalcones as H1N1 Neuraminidase inhibitors , 2018, Medicinal Chemistry Research.

[6]  Hongbao Cao,et al.  In vitro anti-influenza virus effect of total flavonoid from Trollius ledebouri Reichb , 2018, The Journal of international medical research.

[7]  S. Haryana,et al.  Biological activity, quantitative structure–activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs , 2018, Drug design, development and therapy.

[8]  D. Suarez,et al.  Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus. , 2017, Veterinary immunology and immunopathology.

[9]  Bing Niu,et al.  Application of Machine Learning Approaches for Protein-protein Interactions Prediction. , 2017, Medicinal chemistry (Shariqah (United Arab Emirates)).

[10]  Tadahiro Okuyama.  Analysis of optimal timing of tourism demand recovery policies from natural disaster using the contingent behavior method , 2017, Tourism Management.

[11]  M. Fatemi,et al.  Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV‐1 protease inhibitors , 2017, Chemical biology & drug design.

[12]  B. Niu,et al.  2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors , 2017, BioMed research international.

[13]  R. Webby,et al.  Novel Highly Pathogenic Avian A(H5N2) and A(H5N8) Influenza Viruses of Clade 2.3.4.4 from North America Have Limited Capacity for Replication and Transmission in Mammals , 2016, mSphere.

[14]  Vasiliy P. Mishin,et al.  Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses , 2016, Journal of Virology.

[15]  Aixia Yan,et al.  Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors , 2016, Molecular informatics.

[16]  K. Roy,et al.  Be aware of error measures. Further studies on validation of predictive QSAR models , 2016 .

[17]  Shuling Yu,et al.  HQSAR and topomer CoMFA for predicting melanocortin-4 receptor binding affinities of trans-4-(4-chlorophenyl) pyrrolidine-3-carboxamides , 2015 .

[18]  H. Mei,et al.  QSAR and molecular mechanism analysis of N-substituted oseltamivir derivatives as potent avian influenza H5N1 neuraminidase inhibitors , 2015 .

[19]  G. Cima.  47M birds dead in flu outbreak: Egg-laying hens hit hardest, followed by turkeys. , 2015, Journal of the American Veterinary Medical Association.

[20]  M. Killian,et al.  Novel Eurasian Highly Pathogenic Avian Influenza A H5 Viruses in Wild Birds, Washington, USA, 2014 , 2015, Emerging infectious diseases.

[21]  C. Li,et al.  In vitro Antiviral Effects and 3D QSAR Study of Resveratrol Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase , 2015, Chemical biology & drug design.

[22]  M. Tiwari,et al.  Topomer-CoMFA-based predictive modelling on 2,3-diaryl-substituted-1,3-thiazolidin-4-ones as non-nucleoside reverse transcriptase inhibitors , 2015, Medicinal Chemistry Research.

[23]  Jianquan Weng,et al.  Microwave Assistant One Pot Synthesis, Crystal Structure, Antifungal Activities and 3D‐QSAR of Novel 1,2,4‐Triazolo[4,3‐a]pyridines , 2014, Chemical biology & drug design.

[24]  G. Tresadern,et al.  QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. , 2014, Journal of molecular graphics & modelling.

[25]  Shuguang Wu,et al.  Design Some New Type‐I c‐met Inhibitors Based on Molecular Docking and Topomer CoMFA Research , 2014, Molecular informatics.

[26]  Jim-Min Fang,et al.  From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs? , 2014, Future medicinal chemistry.

[27]  Zhuoyong Zhang,et al.  Topomer CoMFA and virtual screening studies of azaindole class renin inhibitors. , 2014, Combinatorial chemistry & high throughput screening.

[28]  Apilak Worachartcheewan,et al.  QSAR Study of H1N1 Neuraminidase Inhibitors from Influenza a Virus , 2014 .

[29]  G. Gao,et al.  Bat-derived influenza-like viruses H17N10 and H18N11 , 2014, Trends in Microbiology.

[30]  Hua Yang,et al.  New World Bats Harbor Diverse Influenza A Viruses , 2013, PLoS pathogens.

[31]  V. Michel,et al.  Risk factors for the introduction of avian influenza virus in breeder duck flocks during the first 24 weeks of laying , 2013, Avian pathology : journal of the W.V.P.A.

[32]  Wenfang Xu,et al.  Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[33]  G. Boivin,et al.  Influenza virus resistance to neuraminidase inhibitors. , 2013, Antiviral research.

[34]  James J. P. Stewart,et al.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters , 2012, Journal of Molecular Modeling.

[35]  C. Yap,et al.  Consensus QSAR model for identifying novel H5N1 inhibitors , 2012, Molecular Diversity.

[36]  I. Wilson,et al.  Influenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid Receptors , 2012, Journal of Virology.

[37]  P. Chiba,et al.  Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones , 2012, Parasitology Research.

[38]  P. Murumkar,et al.  Determination of structural requirements of influenza neuraminidase type A inhibitors and binding interaction analysis with the active site of A/H1N1 by 3D-QSAR CoMFA and CoMSIA modeling , 2011 .

[39]  G. Boivin,et al.  Influenza drug resistance. , 2011, Seminars in respiratory and critical care medicine.

[40]  Ziniu Yu,et al.  Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening , 2011, Journal of molecular modeling.

[41]  Mirko Zimic,et al.  Docking and quantitative structure–activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors , 2011, J. Comput. Aided Mol. Des..

[42]  H. El-Shemy,et al.  Active principle from Moringa oleifera Lam leaves effective against two leukemias and a hepatocarcinoma , 2010 .

[43]  Kuo-Chen Chou,et al.  Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus. , 2010, Biochemical and biophysical research communications.

[44]  Xiang-Qun Xie,et al.  Recent Advances in Fragment-Based QSAR and Multi-Dimensional QSAR Methods , 2010, International journal of molecular sciences.

[45]  Wencong Lu,et al.  Predicting toxic action mechanisms of phenols using AdaBoost Learner , 2009 .

[46]  Deli Liu,et al.  Binding Interaction Analysis of the Active Site and Its Inhibitors for Neuraminidase (N1 Subtype) of Human Influenza Virus by the Integration of Molecular Docking, FMO Calculation and 3D-QSAR CoMFA Modeling , 2008, J. Chem. Inf. Model..

[47]  R. Day,et al.  Avian influenza in the UK: knowledge, risk perception and risk reduction strategies , 2008 .

[48]  Ricardo Vivas-Reyes,et al.  Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA. , 2008, Bioorganic & medicinal chemistry.

[49]  Kuo-Chen Chou,et al.  Multiple field three dimensional quantitative structure–activity relationship (MF‐3D‐QSAR) , 2008, J. Comput. Chem..

[50]  Hong Liu,et al.  QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR , 2006, J. Comput. Aided Mol. Des..

[51]  N. Mills.  ChemDraw Ultra 10.0 CambridgeSoft, 100 CambridgePark Drive, Cambridge, MA 02140. www.cambridgesoft.com. Commercial Price: $1910 for download, $2150 for CD-ROM; Academic Price: $710 for download, $800 for CD-ROM. , 2006 .

[52]  Kuo-Chen Chou,et al.  Predicting protein structural class with AdaBoost Learner. , 2006, Protein and peptide letters.

[53]  Ruisheng Zhang,et al.  QSAR Models for the Prediction of Binding Affinities to Human Serum Albumin Using the Heuristic Method and a Support Vector Machine , 2004, J. Chem. Inf. Model..

[54]  R. Korf,et al.  Best-First Minimax Search , 1996, Artif. Intell..

[55]  A. K. Ghose,et al.  Conformational searching methods for small molecules. I. Study of the sybyl search method , 1993, J. Comput. Chem..

[56]  M. Killian,et al.  Novel Eurasian Highly Pathogenic Avian Influenza A H 5 Viruses in Wild Birds , 2015 .

[57]  Wencong Lu,et al.  Predicting network of drug-enzyme interaction based on machine learning method. , 2014, Biochimica et biophysica acta.

[58]  Jian Zhang,et al.  Farnesyltransferase pharmacophore model derived from diverse classes of inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[59]  BioChem Press,et al.  Semiempirical Topological Index: A Novel Molecular Descriptor for Quantitative Structure-Retention Relationship Studies , 2003 .

[60]  Jonathan Greer,et al.  Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. , 2003, Biochemistry.

[61]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[62]  R. Sidwell,et al.  Influenza virus resistance to neuraminidase inhibitors. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.